Article Information
History
- October 30, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hideaki Kato1,2,
- Kei Miyakawa3,
- Norihisa Ohtake4,5,
- Yutaro Yamaoka3,6,
- Satoshi Yajima7,
- Etsuko Yamazaki7,
- Tomoko Shimada8,
- Atsushi Goto9,
- Hideaki Nakajima2 and
- Akihide Ryo3,*
- 1Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan
- 2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan
- 3Department of Microbiology, Yokohama City University School of Medicine, Yokohama, Japan
- 4Bioscience Division, Research and Development Department, Tosoh Corporation, Tokyo Research Center, Kanagawa, Japan
- 5Advanced Medical Research Center, Yokohama City University, Yokohama, Japan
- 6Life Science Laboratory, Technology and Development Division, Kanto Chemical Co, Inc., Isehara, Japan
- 7Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan
- 8Nursing Department, Yokohama City University Hospital, Yokohama, Japan
- 9Department of Health Data Science, Yokohama City University Graduate School of Data Science, Yokohama, Japan
- ↵*Corresponding author
Akihide Ryo, M.D., Ph. D, Department of Microbiology, Yokohama City University School of Medicine, e-mail: aryo{at}yokohama-cu.ac.jp
Posted October 30, 2021.
Vaccine-induced humoral and cellular immunity against SARS-CoV-2 at 6 months post BNT162b2 vaccination
